MMNFQ (MedMen Enterprises) Stock Based Compensation: $4.9 Mil (TTM As of Mar. 2023)


What is MedMen Enterprises Stock Based Compensation?

MedMen Enterprises MMNFQ -90.00% Stock Based Compensation is $4.9 Mil as of Mar. 2023.

MedMen Enterprises's Stock Based Compensation for the three months ended in Mar. 2023 was $1.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2023 was $4.9 Mil.

MedMen Enterprises Stock Based Compensation Related Terms

MedMen Enterprises Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for MedMen Enterprises's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedMen Enterprises Stock Based Compensation Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.36 32.49 11.07 5.46 5.26

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.57 0.87 0.86 2.11 1.04

MedMen Enterprises Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.9 Mil.

What does a Stock Based Compensation of $4.9 Mil mean?
MedMen Enterprises (MMNFQ) has a Stock Based Compensation of $4.9 Mil as of Mar. 2023. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for MedMen Enterprises and its competitors.
Is MedMen Enterprises' Stock Based Compensation too high?
MedMen Enterprises' current Stock Based Compensation is $4.9 Mil.
How does MedMen Enterprises' Stock Based Compensation compare to ZTS and VTRS?
MedMen Enterprises' Stock Based Compensation of $4.9 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Drug Manufacturers company?
A good Stock Based Compensation depends on the Drug Manufacturers industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for MedMen Enterprises and its competitors. MedMen Enterprises's current Stock Based Compensation is $4.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedMen Enterprises stock overvalued right now?
MedMen Enterprises (MMNFQ) has a current Stock Based Compensation of $4.9 Mil. The current Stock Based Compensation is $4.9 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For MedMen Enterprises (MMNFQ), the current Stock Based Compensation is $4.9 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedMen Enterprises Business Description

Address 8740 S Sepulveda Boulevard, Suite 105, Los Angeles, CA, USA, 90045
MedMen Enterprises Inc is a American cannabis company dedicated to improving life with Cannabis for All. With operations across the United States in California, Nevada, Illinois, Arizona, Massachusetts, and New York, the company has MedMen and LuxLyte brands offering cannabis in consumer-preferred product forms for medical and recreational use. It produces and curates the consumer product assortment for retail operations in its local communities, and drives consumer loyalty with service and engaging in-store experience, combined with reward, delivery, and e-commerce programs.